- $57.37m
- $56.07m
- $35.68m
Brief: Flora Growth Corp On May 6, Received Letter From Nasdaq Stock Market Llc Stating That Company Has Regained Compliance
Brief: Flora Growth Corp Files For Shelf Of Up To 2.1 Million Common Shares By Selling Stockholders - SEC Filing
Brief: Flora Growth On April 16, Entered Purchase Agreement With TruHC Holding GmbH
Brief: Flora Growth Corp To Offer 1.7 Million Common Shares Of Co At An Offering Price Of $1.90 Per Share
Brief: Flora Growth Entered Into Binding Letter Of Intent With TruHC Holding GmbH To Acquire All Of Issued And Outstanding Shares Of TruHC Pharma GmbH
Brief: Flora Growth Corp and Clifford Starke Enter Into Consulting Agreement
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR
Brief: Lifeist Announces Sale Of Non-Core Subsidiary Australian Vapes
Brief: Flora Growth Corp Files For Mixed Shelf Of Up To $80 Million- SEC Filing
Brief: Flora Growth Files For Mixed Shelf Of Up To $10 Mln – SEC Filing
Brief: Flora Growth Corp Says Appoints Clifford Starke As Chief Executive Officer And Dany Vaiman As Chief Financial Officer
U.S. STOCKS ON THE MOVE-Constellation Energy, Cactus, Cardinal Health
U.S. STOCKS ON THE MOVE-CureVac, Aclarion, Baosheng Media
U.S. STOCKS ON THE MOVE-Carvana, Annovis Bio, Aclarion
Flora Growth Corp falls on 1-for-20 reverse stock split
Brief: Flora Growth To Effect Reverse Stock Split
Brief: Flora Growth Reports First Quarter 2023 Financial Results
Brief: Flora Growth Corp Announces Appointment Of Hussein Rakine As CEO
Brief: Flora Growth Receives Cgmp Certification Of Compound Formulation Lab Launches Prescription Cannabis Medicines In Colombia